2.37
price up icon9.22%   0.20
after-market Handel nachbörslich: 2.41 0.04 +1.69%
loading
Schlusskurs vom Vortag:
$2.17
Offen:
$2.2
24-Stunden-Volumen:
111.34K
Relative Volume:
0.55
Marktkapitalisierung:
$77.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-28.30M
KGV:
-3.494
EPS:
-0.6783
Netto-Cashflow:
$-21.30M
1W Leistung:
+10.23%
1M Leistung:
+9.22%
6M Leistung:
-63.14%
1J Leistung:
-90.32%
1-Tages-Spanne:
Value
$2.20
$2.41
1-Wochen-Bereich:
Value
$1.95
$2.41
52-Wochen-Spanne:
Value
$1.60
$26.07

Genelux Corp Stock (GNLX) Company Profile

Name
Firmenname
Genelux Corp
Name
Telefon
805-267-9889
Name
Adresse
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Name
Mitarbeiter
24
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
GNLX's Discussions on Twitter

Genelux Corp Stock (GNLX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-02-15 Eingeleitet The Benchmark Company Speculative Buy

Genelux Corp Aktie (GNLX) Neueste Nachrichten

pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Acquires New Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Sep 25, 2024
pulisher
Sep 19, 2024

Highbridge Capital Management LLC Invests $1.23 Million in Genelux Co. (NASDAQ:GNLX) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Short Interest in Genelux Co. (NASDAQ:GNLX) Decreases By 7.3% - MarketBeat

Sep 18, 2024
pulisher
Sep 14, 2024

Genelux corp insider sells over $170k in company stock - Investing.com India

Sep 14, 2024
pulisher
Sep 13, 2024

Genelux corp insider sells over $170k in company stock - Investing.com

Sep 13, 2024
pulisher
Sep 12, 2024

Genelux director Tyree James L sells shares worth over $4,400 - Investing.com India

Sep 12, 2024
pulisher
Sep 12, 2024

Genelux director Tyree James L sells shares worth over $4,400 - Investing.com

Sep 12, 2024
pulisher
Sep 11, 2024

Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells $63,134.10 in Stock - MarketBeat

Sep 11, 2024
pulisher
Sep 11, 2024

Genelux corp insider sells over $196k in company stock - Investing.com

Sep 11, 2024
pulisher
Sep 11, 2024

ROTH MKM analysts initates a Buy rating for Genelux Corp (GNLX) - Knox Daily

Sep 11, 2024
pulisher
Sep 07, 2024

Genelux Corp insider sells $89.6k in company stock By Investing.com - Investing.com Australia

Sep 07, 2024
pulisher
Sep 06, 2024

Genelux Corp insider sells $89.6k in company stock - Investing.com India

Sep 06, 2024
pulisher
Sep 06, 2024

Genelux Corp insider sells $89.6k in company stock - Investing.com

Sep 06, 2024
pulisher
Sep 06, 2024

Insider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 42,818 Shares of Stock - MarketBeat

Sep 06, 2024
pulisher
Sep 06, 2024

Genelux Corp [NASDAQ: GNLX] Sees Increase in Stock Value - Knox Daily

Sep 06, 2024
pulisher
Sep 06, 2024

Genelux Corp (GNLX) Stock: A Year of Decreases and Increases - The InvestChronicle

Sep 06, 2024
pulisher
Sep 03, 2024

Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference - Yahoo Finance

Sep 03, 2024
pulisher
Sep 02, 2024

Genelux Corp (GNLX) may enjoy gains as insiders got busy in the recent days - Knox Daily

Sep 02, 2024
pulisher
Sep 01, 2024

Aladar Szalay Sells 107,045 Shares of Genelux Co. (NASDAQ:GNLX) Stock - Defense World

Sep 01, 2024
pulisher
Aug 31, 2024

Genelux Corp insider sells over $550k in company stock - Investing.com India

Aug 31, 2024
pulisher
Aug 30, 2024

Genelux Corp insider sells over $550k in company stock - Investing.com

Aug 30, 2024
pulisher
Aug 29, 2024

Analysts Set Genelux Co. (NASDAQ:GNLX) Price Target at $26.75 - MarketBeat

Aug 29, 2024
pulisher
Aug 29, 2024

Genelux (NASDAQ:GNLX) Upgraded to Strong-Buy by Roth Capital - Defense World

Aug 29, 2024
pulisher
Aug 28, 2024

Genelux Corp [GNLX] Insider Activity: An Update for Investors - Knox Daily

Aug 28, 2024
pulisher
Aug 28, 2024

Genelux Co. (NASDAQ:GNLX) Major Shareholder Aladar Szalay Sells 40,000 Shares - Defense World

Aug 28, 2024
pulisher
Aug 28, 2024

Genelux (NASDAQ:GNLX) Receives New Coverage from Analysts at Roth Mkm - Defense World

Aug 28, 2024
pulisher
Aug 27, 2024

Genelux (NASDAQ:GNLX) Coverage Initiated at Roth Mkm - MarketBeat

Aug 27, 2024
pulisher
Aug 27, 2024

Genelux shares gain on Roth/MKM Buy rating, $10 price target - Investing.com

Aug 27, 2024
pulisher
Aug 27, 2024

Genelux initiated with a Buy at Roth MKM - TipRanks

Aug 27, 2024
pulisher
Aug 19, 2024

Equities Analysts Offer Predictions for Genelux Co.’s Q3 2024 Earnings (NASDAQ:GNLX) - Defense World

Aug 19, 2024
pulisher
Aug 18, 2024

Genelux Co. (NASDAQ:GNLX) Sees Large Decrease in Short Interest - MarketBeat

Aug 18, 2024
pulisher
Aug 17, 2024

Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth? - Yahoo Finance

Aug 17, 2024
pulisher
Aug 15, 2024

Genelux's (GNLX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Aug 15, 2024
pulisher
Aug 14, 2024

Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates - StockTitan

Aug 14, 2024
pulisher
Aug 14, 2024

Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates - Yahoo Finance

Aug 14, 2024
pulisher
Aug 13, 2024

Genelux (NASDAQ:GNLX) Trading Down 6.6% - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Genelux (NASDAQ:GNLX) Stock Price Down 6.6% - MarketBeat

Aug 13, 2024
pulisher
Aug 12, 2024

Genelux Corporation (GNLX): A Strong Buy According to Hedge Funds - Yahoo Finance

Aug 12, 2024
pulisher
Aug 05, 2024

Genelux stock plunges to 52-week low at $1.69 amid steep annual decline - Investing.com

Aug 05, 2024
pulisher
Aug 01, 2024

Genelux Corp Unveils Forward-Looking Corporate Presentation - TipRanks

Aug 01, 2024
pulisher
Jul 30, 2024

Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024 - GlobeNewswire Inc.

Jul 30, 2024
pulisher
Jul 30, 2024

Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024 - Yahoo Finance

Jul 30, 2024
pulisher
Jul 14, 2024

Malignant Pleural Effusion Pipeline Drugs Market Forecasted to Reach at Remarkable Pace by 2031 | Lipac Oncology LLC, Clover Biopharmaceuticals, Genelux Corp, Gongwin Biopharm Holdings Co Ltd, Hubei Soundny Bio-Tech Co Ltd – TIMC - TIMC

Jul 14, 2024
pulisher
Jul 10, 2024

Genelux Corporation Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial Evaluating Olvimulogene Nanivacirepvec (Olvi-Vec) in Platinum-Resistant or Refractory Ovarian Cancer in the Journal of the American Medical Association (JA - Quantisnow

Jul 10, 2024
pulisher
Jul 10, 2024

Genelux Corporation Set to Join the Russell 3000® and Russell 2000® Indexes Effective June 26, 2023 - Quantisnow

Jul 10, 2024
pulisher
Jul 10, 2024

Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires - Quantisnow

Jul 10, 2024
pulisher
Jul 09, 2024

Taking a Closer Look At Genelux Corp (GNLX) Following Its Recent Trade - Knox Daily

Jul 09, 2024
pulisher
Jul 09, 2024

Genelux Co. (NASDAQ:GNLX) General Counsel Sean Ryder Sells 5,496 Shares - Defense World

Jul 09, 2024
pulisher
Jul 09, 2024

Genelux Co. (NASDAQ:GNLX) Insider Caroline Jewett Sells 4,961 Shares - Defense World

Jul 09, 2024
pulisher
Jul 08, 2024

Insider Selling: Genelux Co. (NASDAQ:GNLX) General Counsel Sells 5,496 Shares of Stock - MarketBeat

Jul 08, 2024
pulisher
Jul 03, 2024

Genelux Corp (GNLX) may enjoy gains as insiders got busy in the recent days – Knox Daily - Knox Daily

Jul 03, 2024

Finanzdaten der Genelux Corp-Aktie (GNLX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
Kapitalisierung:     |  Volumen (24h):